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Background. Cux-1 is a murine homeodomain protein that
functions as a cell cycle–dependent transcriptional repressor
in proliferating cells. Targets of Cux-1 repression include the
cyclin kinase inhibitors p21 and p27. In the kidney, Cux-1 is
spatially and temporally regulated, and ectopic expression of
Cux-1 in transgenic mice results in renal hyperplasia. Previously,
we observed that Cux-1 is deregulated in cystic kidneys from cpk
mice. Recent studies have suggested a role for the cyclin kinase
inhibitor p21 in the development of polycystic kidney disease
(PKD) in mice lacking PKD1.
Methods. Since p21 is a target of transcriptional repression by
Cux-1, we compared the expression of Cux-1 and p21 in kidneys
from Pkd1 null and cpk mice by immunohistochemistry and
Western blotting. We also evaluated apoptosis and the expres-
sion of the cyclin kinase inhibitor p27 in Pkd1 null and cpk mice
by terminal deoxynucleotidal transferase (TdT)-mediated de-
oxyuridine triphosphate (dUTP) nick-end labeling (TUNEL)
staining, immunohistochemistry, and Western blotting.
Results. In both early and late embryonic kidneys from Pkd1
null mice, Cux-1 was highly and ectopically expressed in normal-
appearing tubule epithelium, interstitial cells, and in the epithe-
lial cells lining the cysts, where it colocalized with proliferating
cell nuclear antigen (PCNA). Increased Cux-1 expression in
Pkd1 null kidneys was also associated with a decrease in p27
expression at late stages of cystogenesis. In cpk kidneys, Cux-
1 was not up-regulated until late stages of cyst development.
Moreover, in contrast to Pkd1 null kidneys, p21 and p27 were
highly expressed in cpk kidneys. In late stages of cystogenesis,
Cux-1 and p21 colocalized in cyst lining cells, which also showed
a high incidence of apoptosis.
Conclusion. These results suggest that cyst development in
Pkd1 null mice and cpk mice proceeds through different mech-
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anisms. In Pkd1 null mice, ectopic expression of Cux-1 is associ-
ated with increased cell proliferation. In contrast, in cpk mice,
ectopic expression of Cux-1 is associated with apoptosis.
Polycystic kidney disease (PKD) is a term applied to
a group of inherited disorders characterized by the pres-
ence of cysts in the kidney. However, multiple organs are
usually affected. Renal pathologies found in essentially
all forms of PKD include increased fluid secretion, matrix
remodeling, cellular proliferation, and apoptosis, with an
altered differentiation of the epithelial cells lining the
renal cysts [1–3]. PKD represents conditions that are
inherited as either autosomal-dominant or autosomal-
recessive traits. Autosomal-dominant PKD (ADPKD)
occurs in 1 in 500 to 1 in 1000 individuals, primarily
as a result of mutations in one of two genes, PKD1
or PKD2 [4–7]. The PKD1 and PKD2 genes encode
polycystin-1 and polycystin-2, respectively. Mutations in
PKD1 are responsible for 85% of ADPKD, while mu-
tations in PKD2 are responsible for 15%. Autosomal-
recessive PKD (ARPKD) is the more rapidly progressive
of these conditions, which can lead to uremia in infants,
is comparatively less frequent (1 in 6000 to 1 in 40,000
live births), and results from mutations in a single gene
PKHD1 [8, 9]. The protein encoded by PKHD1 has been
named polyductin or fibrocystin.
In recent years, the identification of the pathways dis-
rupted by mutations in the polycystins, and leading to
PKD, has been the focus of intense examination. Several
lines of evidence suggest that dysregulation of epithelial
cell growth is a key step in the process. The cystic ep-
ithelium has a high mitotic rate in vivo as measured by
increased levels of expression of markers of proliferation.
In the mouse, several distinct recessively acting mutations
cause PKD phenotypes that mimic human disease [10].
Among these models, the congenital polycystic kidney
(cpk) mutation is the most extensively characterized [11].
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The gene mutated in cpk mice has recently been identi-
fied and found to encode a protein product named cystin
[12]. This protein is found in the primary cilium of ep-
ithelial cells, suggesting that ciliary dysfunction results in
the PKD phenotype in cpk mice. In addition, PKD1 and
PKD2 null mice [13–17] both produce cysts, and also lo-
calize to the primary cilium of epithelial cells [18]. These
observations suggest that these genes may be involved
in a common developmental cascade that is disrupted in
PKD. Recently, the disruption of the gene encoding the
KIF3A subunit of kinesin II specifically in the kidney,
using the Cre-lox system, has linked cilia to cystogenesis
[19]. Kinesin II is required for the anterograde movement
of material in the cilia and loss of KIF3A results in the
absence of tubulin in the cilia.
Cux-1 is a murine homeobox gene that is structurally
related to the Drosophila cut gene. During normal kidney
development, Cux-1 is highly and transiently expressed,
with highest expression restricted to the nephrogenic
zone, in a pattern similar to markers for cell prolifera-
tion [20]. Previous studies have demonstrated a role for
Cux-1 in cell cycle regulation by repression of the cy-
clin kinase inhibitor p21 in G1 to S transition in cultured
cells [21]. In recent studies we showed that Cux-1 also
represses expression of the cyclin kinase inhibitor p27,
and that transgenic mice constitutively expressing Cux-1
develop multiorgan hyperplasia [22], phenocopying p27
null mice [23–25]. During normal kidney development,
p27 is not expressed in the nephrogenic zone, but is up-
regulated in maturing glomeruli and tubules following
down-regulation of Cux-1 [26]. Thus, Cux-1 functions to
promote cell proliferation during early stages of nephro-
genesis through repression of p27 gene expression.
Recent studies have demonstrated a role for
polycystin-1 in cell cycle regulation. Bhunia, et al [27]
showed that polycystin-1 induces expression of the cyclin
kinase inhibitor p21 through activation of the JAK-STAT
signaling pathway in a process requiring polycystin-2. Ac-
cordingly, loss of polycystin-1/2 function would result in
down regulation of p21 expression and increased cell pro-
liferation. Previously, we observed that Cux-1 is ectopi-
cally expressed in cystic kidneys from cpk mice [20]. Since
p21 is a target of transcriptional repression by Cux-1, the
loss of p21 expression may be a common mechanism for
cystogenesis. To begin to address this possibility, we eval-
uated p21 and Cux-1 expression in Pkd1 null and cpk
kidneys.
METHODS
Animals
Colonies of C57BL/6J cpk [11] and BALB/c-Pkd1 null
[28] mice were maintained by breeding heterozygotes at
the University of Kansas Medical Center. Genotyping of
Pkd1 null mice was by Southern blot analysis of tail DNA
using published procedures [28]. Kidneys from 7-, 9-, and
20-day-old normal and cystic cpk mice were perfusion-
fixed, while kidneys from embryonic day 15 (E15) and 19
(E19) normal and cystic null mice were immersion-fixed,
with 4% paraformaldehyde and paraffin-embedded. Nor-
mal mice included both wild-type and heterozygous geno-
types. Animal treatment was in accord with the National
Institutes of Health (NIH) Guide for the Care and Use
of Laboratory Animals.
Immunofluorescence
Whole embryos or isolated metanephroi were im-
mersion fixed in 4% paraformaldehyde and embed-
ded in paraffin. Five micrometer thick tissue sections
were deparaffinized with xylene and rehydrated with
graded ethanols. To obtain adequate signal, the slides
were treated with antigen unmasking solution (Vector,
Burlingame, CA, USA) according to manufacturer’s pro-
tocol, or slides were treated for 10 minutes with trypsin
(1 mg/mL) at 37◦C. To block endogenous auto fluores-
cence sections were incubated with 1 mol/L NH4Cl for
30 minutes. Sections were washed in phosphate-buffered
saline (PBS) with 0.1% Tween 20 (PBST), blocked in
10% BSA at room temperature for 1 hour, and incu-
bated with antibodies diluted in PBS with 3% BSA for
1 hour at room temperature. Antibody dilutions were
1:50 for CCAAT displacement protein (Cux-1) (CDP)
antibody, 1:3000 for proliferating cell nuclear antigen
(PCNA) antibody, 1:100 for p21 antibody, 1:100 for p27
antibody, in 2% blocking serum in PBS. Slides were in-
cubated at room temperature with 100 lL of primary an-
tibody in a humid chamber and then washed four times
in PBST. For Cux-1 and p21 double-labeling experiments
sections were washed with PBST and incubated simulta-
neously with biotin-conjugated horse antirabbit (Vector)
and Texas-Red-conjugated donkey antigoat secondary
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA,
USA). Sections were then washed with PBST and incu-
bated with fluorescein isothiocyanate (FITC)-conjugated
avidin (Vector). For Cux-1 and PCNA double-labeling
experiments, sections were washed with PBST and in-
cubated simultaneously with biotin-conjugated horse an-
tirabbit and Texas-Red-conjugated rabbit antimouse sec-
ondary antibodies (Vector). Sections were then washed
with PBST and incubated with FITC-conjugated avidin
(Vector). Sections were then washed, mounted with
Vectashield (Vector), and viewed with a fluorescence
microscope. Images were captured with an Optronics
Magnafire digital camera (Goleta, CA, USA).
Western blot analysis
Nuclear extracts (30 lg) were solubilized in sodium do-
decyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) sample buffer, electrophoresed on 4% to
15% gradient polyacrylamide gels, and transferred to
nitrocellulose filters as described previously [29]. The
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immunoblot was blocked in 5% nonfat dry milk in PBST
for 1 hour at room temperature. Mouse anti-p21 (Santa
Cruz Biotechnology) antibody was added at a dilution of
1:100. After overnight at 4◦C, filters were washed three
times at room temperature with PBST, and incubated at
room temperature for 1 hour with peroxidase-conjugated
antimouse IgG (1:10,000 dilution) (Sigma Chemical Co.,
St. Louis, MO, USA). Following three additional washes
with PBST, bound antibody was detected by chemi-
luminescence (SuperSignal West Pico Chemilumines-
cent Substrate) (Pierce, Rockford, IL, USA) according
to manufacturer’s instructions, followed by exposure to
x-ray film for 1 minute.
Antibodies
Commercial reagents used were rabbit anti-CDP (Cux-
1) (Santa Cruz Biotechnology, # sc-13024); goat anti-p21
(Santa Cruz Biotechnology); mouse anti-p21 (Santa Cruz
Biotechnology); rabbit anti-p27 (Santa Cruz Biotech-
nology); and mouse anti-PCNA (Sigma Chemical Co.,
# P-8825).
TUNEL assay
Sections were processed for terminal deoxynucleotidal
transferase (TdT)-mediated deoxyuridine triphosphate
(dUTP) nick-end labeling (TUNEL) with the ApopTag
Red In Situ Apoptosis Detection Kit (Intergen Co., Pur-
chase, NY, USA) according to manufacturer’s instruc-
tions. Sections were counterstained with DAPI, cover-
slipped, and visualized on a fluorescence microscope. Im-
ages were captured with an Optronics Magnafire digital
camera. For Cux-1 and TUNEL double-labeling experi-
ments, sections were incubated first with Cux-1 antibody
followed by FITC-conjugated goat antirabbit secondary
antibodies. TUNEL was then performed on the same
sections, according to manufacturer’s directions. Sections
were counterstained with DAPI, cover-slipped, and visu-
alized on a fluorescence microscope. Images were cap-
tured with an Optronics Magnafire digital camera.
RESULTS
We have recently identified a role for Cux-1 in regu-
lating the cell cycle in kidney development by control-
ling the expression of the cyclin kinase inhibitor p27 [22].
Together with the finding that Cux-1 represses p21 in a
cell cycle–dependent manner [21], these studies support
a general role for Cux-1 in growth regulation, and suggest
that ectopic expression of Cux-1 could be a determinant
in disease progression. This is supported by the observa-
tion that ectopic expression of Cux-1 in transgenic mice
results in multiorgan hyperplasia [22], glomerulosclerosis
[30], and hepatic tumors (submitted manuscript).
Recent studies have shown that polycystin-1 regulates
p21 gene expression by signaling through the JAK-STAT
pathway [27]. Accordingly, p21 expression was lost in
PKD1 null mice [27]. Together with the observation that
Cux-1 is ectopically expressed in cystic kidneys isolated
from cpk mice, we considered the possibility that the
down-regulation of p21 was a common mechanism in cys-
togenesis and that ectopic expression of Cux-1 might be
mediating this process. To begin to address these possi-
bilities, we began an expression analysis of p21 and Cux-1
in cystic kidneys from cpk and Pkd1 null mice.
Cux-1 is ectopically expressed in Pkd1 null kidneys
To determine whether Cux-1 was ectopically expressed
in Pkd1 null kidneys, we evaluated Cux-1 expression in
kidneys isolated from early (E15) and late (E19) stages
of cystic progression. During nephrogenesis, Cux-1 ex-
pression is restricted to the uninduced and condensing
mesenchyme, and early nephric structures (comma and
S-shaped bodies) found in the nephrogenic zone, with
lower levels of expression observed in the medulla. This
pattern of expression is highly similar to that of PCNA,
indicating that Cux-1 expression corresponds to prolifer-
ating cells. In cytomegalovirus (CMV)/Cux-1 transgenic
kidneys, the ectopic expression of Cux-1 in the tubules
results in an increase in cell proliferation, and the ec-
topic expression of Cux-1 in mesangial cells results in
an increase in PCNA staining. As shown in Figure 1A,
Cux-1 is highly expressed in the nephrogenic zone of
normal kidneys, but is sharply down-regulated following
S-shaped body stage. In contrast, Cux-1 was highly and
ectopically expressed in Pkd1 null kidneys, both in the
cyst lining cells, and in normal appearing tubule epithe-
lium (Fig. 1B). At both early (E15) and late (E19) stages
of cystogenesis in Pkd1 null kidneys, we observed Cux-1
expression in the nephrogenic zone, in maturing tubules,
and in the cells lining the cysts (Fig. 2B and J). In both
stages, Cux-1 and PCNA were colocalized in the nephro-
genic zone and in the cells lining the cysts, consistent with
the previously described role for Cux-1 in regulating cell
proliferation (Fig. 2D and L). However, in some of the
maturing tubules, we observed ectopic expression of Cux-
1, but not PCNA (Fig. 2H).
Expression of the cyclin kinase inhibitor p27 is reduced
in Pkd1 null kidneys
We next evaluated the expression of p21 in early and
late stage cystic kidneys from Pkd1 null mice. As previ-
ously described, p21 was not detected in kidneys from E15
Pkd1 null mice (data not shown), or in kidneys from E19
Pkd1 null mice (Fig. 3B). In addition to negatively regu-
lating the expression of p21, we have recently shown that
Cux-1 represses p27 gene expression. Moreover, in char-
acterizing the CMV/Cux-1 transgenic mice, we observed
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Fig. 1. Cux-1 is ectopically expressed in kidneys isolated from Pkd1
null mice. (A) Cux-1 expression is restricted to the nephrogenic zone
(NZ) in late embryonic wild-type kidneys. (B) Kidneys isolated from
embryonic day 19 Pkd1 null mice reveal ectopic expression of Cux-1
in both normal tubules (arrow) and in cells lining the cysts (original
magnification 400×; bar, 50 lm).
that p27 knockout mice have similar deregulated growth
defects, and the ectopic expression of Cux-1 resulted in
the loss of p27. In contrast, the p21 knockout mice do not
exhibit growth defects [31]. Thus, one possibility is that
the deregulated expression of Cux-1 in Pkd1 null kidneys
could be repressing the expression of p27, leading to ab-
normal cell proliferation. To test this, we evaluated p27
expression in kidneys from E15 and E19 Pkd1 null and
wild-type mice. During normal kidney development, p27
was highly expressed in maturing glomeruli and tubules,
but was not expressed in the nephrogenic zone, consistent
with repression by Cux-1 in proliferating cells (Fig. 4B
and F). At E15, there was not an obvious difference in
p27 expression between the wild-type and Pkd1 null kid-
Fig. 4. Reduced expression of p27 in kidneys from E19 Pkd1 null mice.
Embryonic day 15 (E15) (A to D) and E19 (E to H) kidneys isolated
from wild-type (A, B, E, F) and Pkd1 null (C, D, G, H) mice were labeled
with an antibody directed against p27. (B and F) p27 is not expressed in
the nephrogenic zone of kidneys isolated from wild-type E19 mice, but
is up-regulated in maturing glomeruli (arrow) and tubules. p27 is ex-
pressed at similar levels to wild-type in cystic kidneys isolated from E15
Pkd1 null mice (D), but p27 expression is reduced in maturing tubules
of cystic kidneys isolated from E19 Pkd1 null mice. p27 expression was
observed in maturing glomeruli of both wild-type and cystic kidneys
(arrows) (original magnification 100×; bar, 200 lm).
neys (Fig. 4B and D). In contrast, p27 expression was
reduced in the tubules and cysts of kidneys from E19
Pkd1 null mice, although some expression was observed
in glomeruli (Fig. 4H).
Cux-1 and PCNA are not colocalized in cystic kidneys
from cpk mice
Previously, we had examined Cux-1 mRNA expression
in kidneys from 21-day-old cystic cpk mice, when cysto-
genesis is well advanced, and primarily of collecting duct
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Fig. 2. Coexpression of Cux-1 and proliferating cell nuclear antigen (PCNA) in the cysts of kidneys from Pkd1 null mice. Early- [embryonic day 15
(E15)] and late- (E19) stage polycystic kidneys were evaluated for expression of Cux-1 and PCNA. Low (A to D) and high (E to H) magnification
images of kidneys isolated from E15 Pkd1 null mice following labeling for Cux-1 (B and F) and PCNA (C and G) expression. At early stages of
cystogenesis (A to H), Cux-1 was ectopically expressed in maturing tubules and in cysts (B and F). PCNA labeling (C and G) showed proliferating
cells lining the cysts, but not in all cells. (D) Merged image (B and C) [boxed region is shown in (H)]. (H) The merged Cux-1 and PCNA images
showed colocalization in cyst lining cells (arrows), but not in some tubules that were positive for Cux-1 only (∗). (I to P) At late stages of cystogenesis,
Cux-1 expression remained elevated in maturing tubules and cysts (J and N), and colocalized with PCNA throughout the cystic kidneys, both in the
nephrogenic zone and in cells lining the cysts (∗ and arrows). Boxed region in (L) is shown at higher magnification in (P) [original magnification (A
to D, I to L) 200×; bar, 100 lm; (E to H, M to P) 400×; bar, 50 lm].
origin [20]. For the present studies, we used antibodies to
localize Cux-1 protein, beginning at postnatal day 7, when
only a few cysts are present, and cysts of both proximal
tubule and collecting duct origin are present. In cystic kid-
neys from 7-day-old mice, Cux-1 was highly expressed in
the nephrogenic zone, where it colocalized with PCNA,
as expected (Fig. 5B to D). In the medulla, we observed
increased PCNA expression in the cyst lining epithelium
(Fig. 5G); however, in contrast to the early staged Pkd1
null kidneys, Cux-1 was not ectopically expressed in the
cysts and did not colocalize with PCNA in these cells
(Fig. 5H). The finding that Cux-1 was not ectopically ex-
pressed in early cystic kidneys, prompted us to reexam-
ine its expression at later stages of cystogenesis. Similar
to our previous results [20], we found that Cux-1 was in-
deed ectopically expressed in the cyst lining cells when
cystogenesis is well advanced (Fig. 5J and N). However,
in contrast to the kidneys from E19 Pkd1 null, we found
that the ectopic expression of Cux-1 did not colocalize
with PCNA in many of the cyst lining cells (Fig. 5P).
Ectopic expression of p21 in cystic kidneys from cpk mice
We next evaluated the expression of p21 in early and
late stage cystic kidneys from cpk mice. While p21 is nor-
mally down-regulated by this stage of kidney develop-
ment (Fig. 6C) [32], to our surprise, p21 was ectopically
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Fig. 3. Reduced expression of p21 in kidneys from Pkd1 null mice. Kidneys isolate from embryonic day 19 (E19) Pkd1 null mice were labeled with
antibodies directed against Cux-1 and p21. (A) Cux-1 is ectopically expressed in cyst lining cells. (B) p21 is not expressed in the in the tubules or
cysts of Pkd1 null kidneys. (C) Since p21 is not expressed in Pkd1 null kidneys, there is no overlap in the merged image (original magnification
200×; bar, 100 lm).
Fig. 5. Differential expression of Cux-1 and proliferating cell nuclear antigen (PCNA) in the cysts of 7-day-old and 20-day-old cpk kidneys. Early-
(7-day-old) and late- (20-day-old) stage polycystic kidneys from cpk mice were labeled with antibodies for Cux-1 (B, F, J, N) and PCNA (C, G, K,
O). (A to H) In kidneys from 7-day-old cpk mice, Cux-1 and PCNA colocalize in the nephrogenic zone (D), but not in the medulla where cysts
are forming (H). Cells lining the cysts are PCNA positive (G), while Cux-1 expression is restricted to interstitial cells (F). (I to P) In kidneys from
20-day-old cpk mice, Cux-1 is ectopically expressed in cells lining the cysts (J, arrow) and (N, arrowhead). While some cells lining the cysts are
PCNA positive (O, arrow), most are not. Merged image (P) shows that Cux-1 is expressed in most of the cyst lining cells, but only a few are also
positive for PCNA (arrow) [original magnification (A to D) 50×; bar, 500 lm; (E to L) 200×; bar, 100 lm; (M to P) 400×; bar, 50 lm).
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expressed both in cyst lining epithelium and in the nor-
mal appearing tubules of the cystic kidneys from 7- and
9-day-old mice (Fig. 6G and K). Double-labeling showed
that Cux-1 and p21 did not colocalize in any of the cells
(Fig. 6H and L). Rather Cux-1 expression was restricted
to the interstitial cells, similar to the expression in wild-
type kidneys (compare Fig. 6B with F and J). In kidneys
from 20-day old cpk mice, we found a colocalization of
Cux-1 and p21, both in normal appearing tubules and
in some of the cyst lining cells (Fig. 7C). To confirm the
increase in p21 expression in the cystic kidneys, we eval-
uated p21 protein expression by Western blot analysis.
Figure 8A shows that p21 protein was increased in cys-
tic kidneys from 16- and 21-day old-mice compared to
the age-matched normal kidneys. We next evaluated the
expression of p27 in cpk kidneys by Western blot analy-
sis. Similar to p21, p27 was also ectopically expressed in
kidneys from cpk mice (Fig. 8B).
There is accumulating evidence that the processes of
cell cycle progression and apoptosis are coupled, through
the utilization of a common set of proteins, including the
cyclin kinase inhibitors. The colocalization of Cux-1 and
p21 in cystic kidneys, together with the differential local-
ization of Cux-1 and PCNA, suggested that Cux-1 was
uncoupled from the role of repressing p21 to promote
cell proliferation. One possibility is that the apparently
disparate expression of Cux-1 and p21 might result in an
apoptotic signal. To test this, we labeled cystic kidneys for
apoptosis using the TUNEL assay. We observed a high
incidence of apoptosis in late-stage cpk kidneys, primar-
ily in the cells lining the cysts (Fig. 9K). In contrast, many
fewer TUNEL-positive cells were observed in early-stage
cpk kidneys, when Cux-1 and p21 were not coexpressed
(Fig. 9H). We also observed some TUNEL-positive cells
in Pkd1null kidneys, both at early and late stages of cys-
togenesis (Fig. 9B and E). However, the number of apop-
totic cells did not increase dramatically between early and
late stages of cystogenesis, and there were many fewer
apoptotic cells in the cysts in the late-stage Pkd1 null
kidney, compared to the late-stage cpk kidney. To de-
termine whether the ectopic expression of Cux-1 was as-
sociated with apoptosis, we performed double-labeling
of Cux-1 with TUNEL on kidney sections from 20-day-
old cpk mice. This showed that many of the many of the
Cux-1–positive cyst lining cells were undergoing apopto-
sis (Fig. 10).
DISCUSSION
In previous studies we demonstrated that Cux-1 ex-
pression in the developing kidney is inversely related to
degree of cellular differentiation, and that Cux-1 expres-
sion is deregulated in the cpk mouse model of PKD [20].
To test the hypothesis that Cux-1 must be down-regulated
for normal kidney development, we generated transgenic
mice constitutively expressing Cux-1 using the CMV pro-
moter. These mice developed multiorgan hyperplasia,
and in the kidney, this resulted from the down regula-
tion of the cyclin kinase inhibitor p27. Promoter reporter
assays revealed that Cux-1 is a repressor of p27 gene ex-
pression. Together with previous studies documenting re-
pression of the cyclin kinase inhibitor p21 by Cux-1, these
results indicate a role for Cux-1 as a cell cycle–dependent
transcription factor in proliferating cells.
Recently, a role for polycystin-1 in regulating the cell
cycle has been established. Bhunia et al [27] showed
that polycystin-1, in association with polycystin-2, acti-
vates the JAK-STAT pathway, thereby up-regulating p21
and inducing cell cycle arrest in G0/G1. Furthermore,
mouse embryos lacking PKD1 had defective STAT1
phosphorylation and p21 induction. Together, these re-
sults suggested a mechanism by which mutations of ei-
ther polycystin-1 or -2 can result in deregulated growth.
Since p21 is a transcriptional target of repression by
Cux-1, we hypothesized that a reduction in p21 might
be a common mechanism of deregulated cell prolifer-
ation in cystogenesis, and this might be mediated by
the ectopic expression of Cux-1. To begin to address
these possibilities, we analyzed the expression of p21
and Cux-1 in cystic kidneys from cpk and Pkd1 null
mice.
In cystic kidneys isolated from Pkd1 null embryos
Cux-1 was highly and ectopically expressed in both cystic
and normal tubules. Moreover, this ectopic expression of
Cux-1 was associated with increased cell proliferation, as
Cux-1 and PCNA were colocalized in cells lining the cysts,
as well as in noncystic tubules. We did not detect p21 in
Pkd1 null kidneys, as has been previously described [27].
Although the regulation of p21 by polycystin-1 and the
loss of p21 in Pkd1 null mice have provided a direct link
between polycystin-1 and cell cycle regulation, there may
be other factors contributing to the increased prolifera-
tion observed in PKD. This is evidenced by the fact that
p21 null mice do not exhibit a cell proliferation defect
[31]. p27 null mice, however, do exhibit cell prolifera-
tion defects leading to multiorgan hyperplasia [23–25].
We have recently identified a potential regulatory loop
between Cux-1 and p27. Cux-1 transgenic mice develop
multiorgan hyperplasia, phenocopying p27 null mice, and
transfection assays showed that Cux-1 represses p27 pro-
moter activity [22]. We therefore examined p27 expres-
sion in cystic kidneys from Pkd1 null mice and found that
p27 expression was reduced compared to wild-type kid-
neys. It is, therefore, plausible that another mechanism of
deregulated cell proliferation in polycystic kidney disease
is repression of p27 by ectopically expressed Cux-1. To-
gether with the changes observed in the Cux-1 transgenic
mice, these results suggest a more direct link to abnormal
cell proliferation. Moreover, since both p21 and p27 are
targets of Cux-1, there may be active repression of p21 by
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Fig. 6. p21 is ectopically expressed in the cysts of kidneys from 7- and 9-day-old cpk mice. (A to D) Kidneys from 7-day-old wild-type mice were
labeled with antibodies for Cux-1 (B) and p21 (C). Cux-1 is expressed primarily in interstitial cells, while p21 expression is not detected. (E to H)
Kidneys from 7-day-old cpk mice were labeled with antibodies for Cux-1 (F) and p21 (G). Cux-1 is expressed primarily in interstitial cells. In contrast
to wild-type, p21 expression is up-regulated in cells lining the cysts (G). Cux-1 and p21 do not colocalize (H). (I to L) Cux-1 and p21 expression in
kidneys from 9-day-old cpk mice localizes similarly to kidney from 7-day-old cpk mice. Cux-1 and p21 do not colocalize (L) (original magnification
200×; bar, 100 lm).
Fig. 7. Colocalization of Cux-1 and p21 in kidneys from 20-day-old cpk mice. Kidneys from 20-day-old cpk mice were labeled with antibodies for
Cux-1 and p21. Cux-1 (A) and p21 (B) are ectopically expressed in both cyst lining cells and in normal appearing tubule epithelium (arrow). In
some tubules, Cux-1 and p21 expression colocalize (C) (original magnification 400×; bar, 50 lm).
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Fig. 8. Ectopic expression of p21 and p27 protein in cpk kidneys. Thirty
micrograms of nuclear extract prepared from kidneys from 16- and 21-
day-old wild type (WT) and cpk mice was subjected to sodium dode-
cyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred to nitrocellulose membranes. (A) The presence of p21 protein
was detected by using a monoclonal antibody to p21. p21 was detected
at high levels in cpk kidneys, but not in age-matched wild-type kidneys.
(B) Similarly, p27 was detected at high levels in cpk kidneys, but not in
age-matched wild-type kidneys. Equal loading of protein was confirmed
by Ponceau S staining. Molecular weight standards are shown on right.
the ectopically expressed Cux-1contributing to the loss of
p21 gene activation in Pkd1 null mice.
In contrast to Pkd1 null mice, our results showed that
p21 was ectopically expressed in the cystic kidneys from
cpk mice, primarily in the cells lining the cysts. In addi-
tion, we observed an increased expression of p27 in cpk
kidneys. Furthermore, during the early stages of cysto-
genesis, Cux-1 was not ectopically expressed. Cux-1 was
localized to interstitial cells in both wild-type and cpk
cystic kidneys, but not in the cystic cells. This appeared
to be in contrast to our previous studies showing ectopic
expression of Cux-1 in cystic kidneys from 21-day-old cpk
mice. However, when we examined Cux-1 expression in
kidneys from 20-day-old cpk mice, we observed that Cux-
1 was indeed ectopically expressed in cystic and noncystic
tubules. In addition, p21 was also ectopically expressed at
this stage, and colocalized with Cux-1 in many of the cells.
We also observed a high incidence of apoptosis in the cells
lining the cysts, as has been observed by others [33–35].
There is accumulating evidence that the processes of cell
cycle progression and apoptosis are coupled, through the
utilization of a common set of proteins, including p21.
One possibility is that in late stages of cystic disease in
the cpk kidney, Cux-1 was uncoupled from the role of re-
pressing p21 and promoting cell proliferation, to a role in
apoptosis. This is supported by the observation that many
of the cells ectopically expressing Cux-1 were also under-
going apoptosis. One possibility is that the co-expression
of Cux-1 and p21 results in the direct activation of the
apoptotic pathway. Alternatively, apoptosis may be sec-
ondary to these cells receiving multiple contradictory sig-
nals. Since we were unable to definitively show that the
cells expressing both Cux-1 and p21 are also apoptotic, by
simultaneously labeling for Cux-1, p21, and TUNEL, the
mechanism remains unclear. However, the high levels of
apoptosis were not observed at the early stages of cysto-
genesis in the cpk kidneys, even though p21 was highly
expressed in the cyst lining cells. Nor were high levels
of apoptosis observed in Pkd1 null kidneys, even though
Cux-1 was highly expressed in the cyst lining cells. Taken
together, these results suggest that the ectopic expression
of both Cux-1 and p21 is associated with the increase in
apoptosis observed in the 20-day-old cpk kidneys. Recent
studies have shown that polycystin-1 is overexpressed in
cpk kidneys [36]. Thus, it is possible that this increase in
polycystin-1 results in the ectopic expression of p21 in the
cpk kidneys.
While ectopic expression of Cux-1 correlated with in-
creased cell proliferation in Pkd1 null kidneys, this was
not the case in cpk kidneys. Cux-1 and PCNA colocalized
in the nephrogenic zone, but not in the cyst lining cells of
the kidneys from 7- or 9-day-old cpk mice. In addition, the
cyclin kinase inhibitors p21 and p27 were up-regulated in
late stage cpk kidneys, but were down-regulated in late-
stage PKD1 null kidneys. One possible explanation for
these expression differences is that cystogenesis in cpk
and Pkd1 null kidneys proceed through different mecha-
nisms. In the case of the Pkd1 null mice, the cysts develop
concurrently with nephron formation. Thus, the ectopic
expression of Cux-1 likely results in an exaggerated, nor-
mal function of Cux-1. During normal kidney develop-
ment, Cux-1 functions to repress p27 in the nephrogenic
zone allowing cells to proliferate. Accordingly, in the
Pkd1 null cystic kidneys, the ectopic expression of Cux-1
in maturing and cystic tubules would repress p27, pro-
moting cell proliferation. This is supported by the colo-
calization of Cux-1 and PCNA in these cells. In the case of
the cpk mice, gross cyst formation occurs primarily dur-
ing postnatal renal maturation, at a time when Cux-1 is
normally down-regulated, and after terminal differentia-
tion. Moreover, Cux-1 is not ectopically expressed until
the cysts are very large and encompass most of the kidney.
Consequently, during the early stages of cystogenesis in
the cpk mouse, cell proliferation is Cux-1 independent.
At later stages of cystogenesis in the cpk mouse, Cux-1 ex-
pression colocalizes with p21, and appears to be related to
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Fig. 9. Increased apoptosis in late stage cpk kidneys. (A) The terminal deoxynucleotidal transferase (TdT)-mediated deoxyuridine triphosphate
(dUTP) nick-end labeling (TUNEL) method was used to identify apoptotic cells in early (B and H) and late (E and K) stages of cystogenesis in
kidneys from Pkd1 null (B and E) and cpk (H and K) mice. (B) Apoptotic cells were observed primarily in the nephrogenic zone of the kidneys
from embryonic day 15 (E15) Pkd1 null mice, with few apoptotic cells in the cysts (∗). (C) The TUNEL staining was merged with the nuclear stain
(DAPI) (A) to identify TUNEL-positive cells. (D to F) Few apoptotic cells are observed among the cyst lining cells in the kidneys from E19 Pkd1
null mice (arrow). (G to I) Similarly, there are few apoptotic cells found among the cyst lining cells in the kidneys from 7-day-old cpk mice (arrow).
(J to L) In contrast, numerous TUNEL-positive cells are observed among the cells lining the cysts in the kidneys from 20-day-old cpk mice. The
merged TUNEL and DAPI image (L) shows that TUNEL-positive staining corresponds to nuclei (original magnification 200×; bar, 100 lm).
Fig. 10. Colocalization of Cux-1 and terminal deoxynucleotidal transferase (TdT)-mediated deoxyuridine triphosphate (dUTP) nick-end labeling
(TUNEL) cyst lining cells of late-stage cpk kidneys. (A) To determine whether Cux-1–positive cells were also apoptotic, sections of kidneys from
20-day-old cpk mice were labeled with antibodies directed against Cux-1, followed by TUNEL labeling. (B) Cux-1 was ectopically expressed in
many of the cyst lining cells (arrows). (C) Apoptotic cells were observed among many of the cyst lining cells (arrows). (D) The merged image
shows that most of the cyst lining cells were both Cux-1 and TUNEL-positive (arrow), while most of the interstitial cells only expressed Cux-1
(arrowheads) (original magnification 400×; bar, 50 lm).
increased levels of apoptosis and not proliferation. Taken
together, these results suggest that in postnatal cystic dis-
ease, Cux-1 function is uncoupled from the normal regu-
lation of p21 and p27 gene expression.
Recent studies demonstrate that the proteins encoded
by the PKD1 (polycystin-1), PKD2 (polycystin-2), Tg737
(polaris), and cpk (cystin) genes are colocalized in re-
nal cilia [18]. These results suggest that disruption of the
genes encoding these proteins may disrupt ciliary func-
tion to a greater or lesser extent, altering a common sig-
naling pathway. One possibility is that Cux-1 expression
and/or function, is regulated by this common signaling
pathway, and levels of Cux-1 expression, and/or changes
in function, may contribute to the severity of the cystic
phenotype. Our results suggest that the role of Cux-1 as a
transcriptional regulator of the cell cycle is retained in the
Pkd1 null kidneys, but expression is altered. In contrast,
in the cpk kidneys, this function of Cux-1 does not appear
to play an important role, at least in the early stages of
cystogenesis. Rather, the ectopic expression of Cux-1 is
associated with apoptosis. It is unlikely that this simply re-
sults from increased expression of Cux-1 in cells following
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terminal differentiation, since no increase in apoptosis
was observed in the renal tubules of adult Cux-1 trans-
genic mice [22]. Moreover, the studies on the Cux-1 trans-
genic mice demonstrate that ectopic expression of Cux-1
alone is insufficient to cause cyst development. Rather,
the levels of Cux-1 expression, or changes in Cux-1 func-
tion, may modify cyst progression. Future studies will be
required to delineate the role of Cux-1 in cyst progression.
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